Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors

Molecular Endocrinology

Volumn 17, Issue 4, 2003, Pages 628-642

  Qiu, Ming ^a   Olsen, Abby ^a   Faivre, Emily ^a   Horwitz, Kathryn B ^b   Lange, Carol A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALANINE; EPIDERMAL GROWTH FACTOR; GESTAGEN; LEPTOMYCIN B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROGESTERONE RECEPTOR; SERINE;

ARTICLE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WILD TYPE;

ACETYLCYSTEINE; ACTIVE TRANSPORT, CELL NUCLEUS; BREAST NEOPLASMS; BUTADIENES; CELL NUCLEUS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; CYTOPLASM; EPIDERMAL GROWTH FACTOR; FATTY ACIDS, UNSATURATED; HUMANS; LIGANDS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MULTIENZYME COMPLEXES; MUTATION; NITRILES; PHOSPHORYLATION; PROMEGESTONE; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, PROGESTERONE; SERINE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0037385535     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0378     Document Type: Article

References (57)

1. Guiochon-Mantel A, Loosfelt H, Lescop P, Christin-Maitre S, Perrot-Applanat M, Milgrom E 1989 Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers. Cell 57:1147-1154
2. Zhang Y, Xiong Y 2001 A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292:1910-1915
3. Lange CA, Shen T, Horwitz KB 2000 Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 97: 1032-1037
4. Rao KV, Peralta WD, Greene GL, Fox CF 1987 Cellular progesterone receptor phosphorylation in response to ligands activating protein kinases. Biochem Biophys Res Commun 146:1357-1365
5. Zhang Y, Beck CA, Poletti A, Edwards DP, Weigel NL 1995 Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol Endocrinol 9:1029-1040
6. Salghetti SE, Caudy AA, Chenoweth JG, Tansey WP 2001 Regulation of transcriptional activation domain function by ubiquitin. Science 293:1651-1653
7. Ferdous A, Gonzalez F, Sun L, Kodadek T, Johnston SA 2001 The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol Cell 7:981-991
8. Alarid ET, Bakopoulos N, Solodin N 1999 Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 13:1522-1534
9. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW 1999 Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96: 1858-1862
10. Wijayaratne AL, McDonnell DP 2001 The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 276:35684-35692
11. Dace A, Zhao L, Park KS, Furuno T, Takamura N, Nakanishi M, West BL, Hanover JA, Cheng S 2000 Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. Proc Natl Acad Sci USA 97:8985-8990
12. Shen T, Horwitz KB, Lange CA 2001 Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol Cell Biol 21:6122-6131
13. Imhof MO, McDonnell DP 1996 Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Mol Cell Biol 16: 2594-2605
14. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, O'Malley BW 1999 The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol 19: 1182-1189
15. Clemm DL, Sherman L, Boonyaratanakornkit V, Schrader WT, Weigel NL, Edwards DP 2000 Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol Endocrinol 14:52-65
16. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinase/p21Ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300
17. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M, Auricchlo F 1998 Activation of the Src/p21(ras)/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17:2008-2018
18. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP 1999 Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 96:4686-4691
19. Lim CS, Baumann CT, Htun H, Xian W, Irie M, Smith CL, Hager GL 1999 Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras. Mol Endocrinol 13:366-375
20. Lange CA, Richer JK, Shen T, Horwitz KB 1998 Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways. J Biol Chem 273: 31308-31316
21. Richer JK, Lange CA, Manning NG, Owen G, Powell R, Horwitz KB 1998 Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. J Biol Chem 273:31317-31326
22. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW 1991 Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254: 1636-1639
23. Mani SK, Allen JM, Lydon JP, Mulac-Jericevic B, Blaustein JD, DeMayo FJ, Conneely O, O'Malley BW 1996 Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol Endocrinol 10:1728-1737
24. Bamberger AM, Bamberger CM, Gellersen B, Schulte HM 1996 Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc Natl Acad Sci USA 93:6169-6174
25. Fornerod M, Ohno M, Yoshida M, Mattaj IW 1997 CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060
26. Lohrum MA, Woods DB, Ludwig RL, Balint E, Vousden KH 2001 C-terminal ubiquitination of p53 contributes to nuclear export. Mol Cell Biol 21:8521-832
27. Takimoto GS, Hovland AR, Tasset DM, Melville MY, Tung L, Horwitz KB 1996 Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. J Biol Chem 271:13308-13316
28. Weigel NL 1996 Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319: 657-667
29. Krusekopf S, Chauchereau A, Milgrom E, Henderson D, Cato AC 1991 Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells. J Steroid Biochem Mol Biol 40:239-245
30. Haraguchi S, Good RA, Engelman RW, Greene S, Day NK 1997 Prolactin, epidermal growth factor or transforming growth factor-α activate a mammary cell-specific enhancer in mouse mammary tumor virus-long terminal repeat. Mol Cell Endocrinol 129:145-155
31. Owen GI, Richer JK, Tung L, Takimoto G, Horwitz KB 1998 Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 273: 10696-10701
32. tk;4Jacobsen BM, Richer JK, Schittone SA, Horwitz KB 2002 New human breast cancer cells to study progesterone receptor (PR) isoform ratio effects and ligand-independent gene regulation. J Biol Chem 20: 27793-27800
33. Labriola L, Salatino M, Proietti CJ, Pecci A, Coso OA, Kornblihtt AR, Charreau EH, Elizalde PV 2003 Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Mol Cell Biol 23:1095-1111
34. Mani SK, Allen JM, Clark JH, Blaustein JD, O'Malley BW 1994 Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior. Science 265:1246-1249
35. Dickson RB, Johnson MD, Bano M, Shi E, Kurebayashi J, Ziff B, Martinez-Lacaci I, Amundadottir LT, Lippman ME 1992 Growth factors in breast cancer: mitogenesis to transformation. J Steroid Biochem Mol Biol 43:69-78
36. Woodward TL, Xie JW, Haslam SZ 1998 The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland. J Mammary Gland Biol Neoplasia 3:117-131
37. Lange CA, Richer JK, Horwitz KB 1999 Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 13:829-836
38. Dickson RB, Lippman ME 1997 Cancer of the breast. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven Publishers; 1541-1616
39. Dickson RB, Lippman ME 1992 Molecular basis of breast cancer. Boston: Kluwer Academic Publishers
40. De Bortoli M, Dati C 1997 Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland. J Mammary Gland Biol Neoplasia 2:175-185
41. Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D 2001 Hyperactivation of MAPK induces loss of ERα expression in breast cancer cells. Mol Endocrinol 15:1344-1359
42. deFazio A, Chiew YE, Sini RL, Janes PW, Sutherland RL 2000 Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines. Int J Cancer 87:487-498
43. McGuire WL 1978 Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5:428-433
44. Smith DF, Toft DO 1993 Steroid receptors and their associated proteins. Mol Endocrinol 7:4-11
45. Milad M, Sullivan W, Diehl E, Altmann M, Nordeen S, Edwards DP, Toft DO 1995 Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A. Mol Endocrinol 9:838-847
46. Pratt WB, Czar MJ, Stancato LF, Owens JK 1993 The hsp56 immunophilin component of steroid receptor heterocomplexes: could this be the elusive nuclear localization signal-binding protein? J Steroid Biochem Mol Biol 46:269-279
47. Guiochon-Mantel A, Lescop P, Christin-Maitre S, Loosfelt H, Perrot-Applanat M, Milgrom E 1991 Nucleo-cytoplasmic shuttling of the progesterone receptor. EMBO J 10:3851-3859
48. Guiochon-Mantel A, Delabre K, Lescop P, Milgrom E 1994 Nuclear localization signals also mediate the outward movement of proteins from the nucleus. Proc Natl Acad Sci USA 91:7179-7183
49. Tyagi RK, Amazit L, Lescop P, Milgrom E, Guiochon-Mantel A 1998 Mechanisms of progesterone receptor export from nuclei: role of nuclear localization signal, nuclear export signal, and ran guanosine triphosphate. Mol Endocrinol 12:1684-1695
50. Savory JG, Hsu B, Laquian IR, Giffin W, Reich T, Hache RJ, Lefebvre YA 1999 Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 19:1025-1037
51. Liu J, DeFranco DB 2000 Protracted nuclear export of glucocorticoid receptor limits its turnover and does not require the exportin 1/CRM1-directed nuclear export pathway. Mol Endocrinol 14:40-51
52. Gottifredi V, Prives C 2001 Molecular biology. Getting p53 out of the nucleus. Science 292:1851-1852
53. Rape M, Hoppe T, Gorr I, Kalocay M, Richly H, Jentsch S 2001 Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 107:667-677
54. Seternes OM, Johansen B, Hegge B, Johannessen M, Keyse SM, Moens U 2002 Both binding and activation of p38 mitogen-activated protein kinase (MAPK) play essential roles in regulation of the nucleocytoplasmic distribution of MAPK-activated protein kinase 5 by cellular stress. Mol Cell Biol 22:6931-6945
55. Sartorius CA, Groshong SD, Miller LA, Powell RL, Tung L, Takimoto GS, Horwitz KB 1994 New T47D breast cancer cell lines for the independent study of progesterone B-and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54:3868-3877
56. Estes PA, Suba EJ, Lawler-Heavner J, Elashry-Stowers D, Wei LL, Toft DO, Sullivan WP, Horwitz KB, Edwards DP 1987 Immunologic analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies. Biochemistry 26:6250-6262
57. Smith CL, Wolford RG, O'Neill TB, Hager GL 2000 Characterization of transiently and constitutively expressed progesterone receptors: evidence for two functional states. Mol Endocrinol 14:956-971